Phoenix PharmaLabs

Phoenix PharmaLabs is addressing the opioid crisis by developing a potent, safe, non-addictive painkiller.

CLOSED

see other companies in category:

visit:
Phoenix PharmaLabs Website

minimum raise

$10,000

maximum raise

$1,070,000

start date

10/15/2018

stop date

03/30/2019

security type

Common Stock

investment minimum

$1

raised to date

$1,102,553

reporting date

CLOSED

number of investors

Not Known

percent of minimum raised

11,026%

percent of maximum raised

103%

likelihood of reaching max

Likely to Reach Max

dollars per day to reach max

$0

dollars per day committed

$6,642

dollars per day - category-

$2,152

dollars per day committed - all companies

$956
More SEC Filing Data on Phoenix PharmaLabs from Crowdfilings.com

Phoenix PharmaLabs has created a safe and non-addictive painkiller that they hope will combat the opioid epidemic and crisis. This preclinical, potent treatment can be used for both pain and addiction treatment. So far, it’s been tested in animal studies to be effective, does not produce withdrawal, does not cause death from overdose, and does not cause constipation. The US Army and the NIH have already been provided a $3M grant, and with this campaign, Phoenix PharmaLabs hopes to accelerate the advancement of the drug and perform key studies in humans.